Suchergebnisse
Suchergebnisse:
Vor 2 Tagen · Stay on top of latest health news from Harvard Medical School. Plus, get a FREE copy of the Best Diets for Cognitive Fitness.
Vor 3 Tagen · Honors received by HMS faculty, postdocs, staff, and students. Compiled by JEFFRY STANTON May 21, 2024 Awards and Recognitions. 6 min read. Five Harvard Medical School faculty members are among the 144 individuals elected this month to the National Academy of Sciences in recognition of their distinguished and continuing achievements in original ...
Vor 5 Tagen · Removing race from equations that estimate lung function will shift the categorization of disease severity across patient populations, moving more Black individuals into an advanced disease category, according to new research led by scientists at Harvard Medical School.
Vor einem Tag · A fourth-year student at Harvard Medical School, Lievano said he faced a “constant tension” between the responsibility to do right by his patients and the need to maintain his own mental health.
Vor 2 Tagen · Indeed, we found that for non-US medical school graduates the median time from medical school graduation to K award was 15.3 years (range, 8.8–27.2 years), whereas for US medical school graduates it was 9.1 years (range, 4.2–16.8 years) (P < 0.001). However, there was no substantial difference in median time from medical school graduation to IK2 award if the non-US medical school graduate ...
Vor einem Tag · A fourth-year student at Harvard Medical School, Lievano said he faced a “constant tension” between the responsibility to do right by his patients and the need to maintain his own mental health. Throughout the course of their training to become doctors, many medical school students have come to face the same challenges as Lievano.
Vor 2 Tagen · The therapeutic approach was developed in the laboratory of Michael Young, PhD, InGel co-founder, director of the Minda de Gunzburg Center for Retinal Regeneration at Mass Eye and Ear, and co-director of the Ocular Regenerative Medicine Institute at Harvard Medical School. Dr. Young developed the cell therapy used in ReNeuron’s RP clinical trial, which was stopped in Phase 2.
